Paper26320110
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
Roffi M and 19 others. Eur Heart J, 2016. Cited by 4,413 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Papers, record 26320110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26320110
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Coronary Syndrome | Major topic |
| Non-ST Elevated Myocardial Infarction | Major topic |
| Algorithms | |
| Angina Pectoris | |
| Anticoagulants | |
| Biomarkers | |
| Cardiotonic Agents | |
| Coronary Angiography | |
| Diagnosis, Differential | |
| Electrocardiography | |
| Hemorrhage | |
| Humans | |
| Long-Term Care | |
| Percutaneous Coronary Intervention | |
| Physical Examination | |
| Platelet Aggregation Inhibitors | |
| Platelet Glycoprotein GPIIb-IIIa Complex | |
| Purinergic P2Y Receptor Antagonists | |
| Risk Assessment |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_U137686849 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials21
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02741817 | WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS) | Background | ClinicalTrials.gov | |
| NCT03023020 | Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen | Background | ClinicalTrials.gov | |
| NCT03087175 | MGuard Stent and Microcirculation | Background | ClinicalTrials.gov | |
| NCT03145675 | Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) | Results | ClinicalTrials.gov | |
| NCT03205514 | Multimodality Investigation of Intermediate Culprit Lesion With Negative FFR in NSTE-ACS | Background | ClinicalTrials.gov | |
| NCT03378934 | Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention | Background | ClinicalTrials.gov | |
| NCT03415386 | Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus | Background | ClinicalTrials.gov | |
| NCT03445546 | Platelet Function in Resuscitated Patients-2 | Results | ClinicalTrials.gov | |
| NCT03583320 | Trial of Cardiac CT in Acute Chest Patients With Intermediate Level Initial High-sensitivity Cardiac Troponin | Background | ClinicalTrials.gov | |
| NCT03621111 | A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction | Results | ClinicalTrials.gov | |
| NCT03621501 | Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease | Results | ClinicalTrials.gov | |
| NCT03634384 | Rapid Use of High-sensitive Cardiac Troponin I for ruling-in and Ruling-out of Acute Myocardial Infarction | Background | ClinicalTrials.gov | |
| NCT03863652 | Optimal Hemostasis Duration for Percutaneous Coronary Intervention Via Snuffbox Approach | Results | ClinicalTrials.gov | |
| NCT03869268 | The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin | Background | ClinicalTrials.gov | |
| NCT03976921 | Impact of Stress CT Myocardial Perfusion on Downstream Resources and Prognosis | Background | ClinicalTrials.gov | |
| NCT04043091 | Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction | Background | ClinicalTrials.gov | |
| NCT04140019 | Early Cardiac Magnetic Resonance Imaging in Suspected Non-ST-Elevation Myocardial Infarction | Background | ClinicalTrials.gov | |
| NCT04714736 | DyeVert System and Contrast-induced Acute Kidney Injury | Results | ClinicalTrials.gov | |
| NCT05752188 | Prognostic Value of Cardiovascular Risk of sST2 and Troponin I-hs in Patients With Acute Chest Pain | Background | ClinicalTrials.gov | |
| NCT06763835 | Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting Prognosis | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 26,536,584 | Misleading high-sensitivity troponin algorithm for NSTEMI in the ESC guidelines. | https://conductscience.org/library/papers/26536584 | PubMed |
| Comment in | 35,450,949 | What is an acceptable risk of major adverse cardiac event soon after discharge from emergency? The patient's perspective. | https://conductscience.org/library/papers/35450949 | PubMed |
Cited by1,929
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,413 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,983,156 | Vascular Access Site, Frailty and Outcomes in Older Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes. | Cardiol Ther | 2026 | https://conductscience.org/library/papers/42983156 | PubMed |
| 42,897,896 | A Contemporary Review of Myocardial Infarction with Emphasis on Clinical Trials and Therapeutic Approaches. | Curr Hypertens Rev | 2026 | https://conductscience.org/library/papers/42897896 | PubMed |
| 42,760,559 | Impact of a pharmacist adherence intervention on medication beliefs and drug-related problems in coronary patients - a process evaluation of the MIMeRiC trial. | BMC Health Serv Res | 2026 | https://conductscience.org/library/papers/42760559 | PubMed |
| 42,701,926 | Redefining NSTE-ACS risk assessment: The synergistic power of CT-enhanced GRACE 2.0 score for advanced prognosis. | Int J Cardiovasc Imaging | 2026 | https://conductscience.org/library/papers/42701926 | PubMed |
| 42,671,614 | Delayed intracardiac remote ischemic preconditioning reduces infarct size in remote myocardium of pigs. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/42671614 | PubMed |
| 42,643,115 | Six-Week Changes in Global Longitudinal Strain and Rehabilitation Outcomes After Enhanced External Counterpulsation Following PCI for Myocardial Infarction: An Analysis of a Pre-Existing Matched Cohort. | Echocardiography | 2026 | https://conductscience.org/library/papers/42643115 | PubMed |
| 42,631,158 | Edoxaban plus aspirin de-escalation strategy versus continuous dual antithrombotic therapy in the perioperative period for patients with atrial fibrillation undergoing carotid artery stenting: a retrospective cohort study. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42631158 | PubMed |
| 42,597,764 | Prognostic value of GRACE and EDACS scores in non-STEMI patients presenting to the emergency department. | Open Med (Wars) | 2026 | https://conductscience.org/library/papers/42597764 | PubMed |
| 42,582,111 | Circulating exosomal miRNA in acute coronary syndrome: mechanisms, clinical relevance and future directions. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42582111 | PubMed |
| 42,569,403 | Diagnosis and management of ACS in patients with ESRD on haemodialysis: a comprehensive review. | Br J Cardiol | 2025 | https://conductscience.org/library/papers/42569403 | PubMed |
| 42,566,699 | Secondary prevention of myocardial infarction in people with dementia: a multi-jurisdictional retrospective cohort study in Asia, Europe and the USA. | Age Ageing | 2026 | https://conductscience.org/library/papers/42566699 | PubMed |
| 42,540,564 | Long-term prognosis in patients suffering from myocardial infarction with non-obstructive coronary arteries, ST-segment elevation myocardial infarction, infective myocarditis and tako-tsubo cardiomyopathy - all-cause mortality comparison. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42540564 | PubMed |
| 42,534,855 | The HEART score has less utility with high sensitivity troponin. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534855 | PubMed |
| 42,518,941 | Clinical outcomes of invasive versus conservative strategies for very high-risk patients with non-ST-elevation acute coronary syndrome: an observational cohort study in a real-world population of China. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42518941 | PubMed |
| 42,452,585 | The Evolution of Accelerated Diagnostic Protocols for Suspected Myocardial Infarction. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452585 | PubMed |
| 42,439,667 | Identifying Platelet Lipidomic Networks and Evaluating Machine-Learning Models to Identify Distinctive Features Between Chronic and Acute Coronary Syndrome. | Cells | 2026 | https://conductscience.org/library/papers/42439667 | PubMed |
| 42,428,478 | A machine learning model for predicting short-term in-hospital mortality in acute myocardial infarction with coexisting chronic obstructive pulmonary disease. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42428478 | PubMed |
| 42,390,391 | Wearable Electrocardiogram Technologies for the Early Detection of Acute Coronary Syndromes. | JACC Asia | 2026 | https://conductscience.org/library/papers/42390391 | PubMed |
| 42,363,698 | Prasugrel: Reassessing Its Role in Contemporary Antiplatelet Therapy. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42363698 | PubMed |
| 42,355,612 | Clinical Gray Zones of Cardiac Troponin Interpretation in the Emergency Department: When Increased Concentrations Do Not Equal Acute Coronary Syndrome. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355612 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ENOXAPARIN | CHEMBL1201685 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201685 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26320110
GET https://conductscience.org/api/papers/v1/26320110/trials?page=2